JP2021534385A5 - - Google Patents

Info

Publication number
JP2021534385A5
JP2021534385A5 JP2021506950A JP2021506950A JP2021534385A5 JP 2021534385 A5 JP2021534385 A5 JP 2021534385A5 JP 2021506950 A JP2021506950 A JP 2021506950A JP 2021506950 A JP2021506950 A JP 2021506950A JP 2021534385 A5 JP2021534385 A5 JP 2021534385A5
Authority
JP
Japan
Prior art keywords
level
risk
patient
proadm
fragments
Prior art date
Application number
JP2021506950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021534385A (ja
JP7402858B2 (ja
JPWO2020030745A5 (https=
Filing date
Publication date
Priority claimed from EP18200907.6A external-priority patent/EP3608673A1/en
Application filed filed Critical
Publication of JP2021534385A publication Critical patent/JP2021534385A/ja
Publication of JPWO2020030745A5 publication Critical patent/JPWO2020030745A5/ja
Publication of JP2021534385A5 publication Critical patent/JP2021534385A5/ja
Priority to JP2023208353A priority Critical patent/JP2024023615A/ja
Application granted granted Critical
Publication of JP7402858B2 publication Critical patent/JP7402858B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021506950A 2018-08-08 2019-08-08 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ Active JP7402858B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023208353A JP2024023615A (ja) 2018-08-08 2023-12-11 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP18188098.0 2018-08-08
EP18188098 2018-08-08
EP18200907.6A EP3608673A1 (en) 2018-08-08 2018-10-17 Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease
EP18200907.6 2018-10-17
PCT/EP2019/071334 WO2020030745A1 (en) 2018-08-08 2019-08-08 Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023208353A Division JP2024023615A (ja) 2018-08-08 2023-12-11 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ

Publications (4)

Publication Number Publication Date
JP2021534385A JP2021534385A (ja) 2021-12-09
JPWO2020030745A5 JPWO2020030745A5 (https=) 2022-08-15
JP2021534385A5 true JP2021534385A5 (https=) 2022-08-15
JP7402858B2 JP7402858B2 (ja) 2023-12-21

Family

ID=63207559

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021506950A Active JP7402858B2 (ja) 2018-08-08 2019-08-08 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ
JP2023208353A Abandoned JP2024023615A (ja) 2018-08-08 2023-12-11 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023208353A Abandoned JP2024023615A (ja) 2018-08-08 2023-12-11 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ

Country Status (7)

Country Link
US (1) US20210293830A1 (https=)
EP (2) EP3608673A1 (https=)
JP (2) JP7402858B2 (https=)
CN (1) CN113056675A (https=)
BR (1) BR112021002281A2 (https=)
CA (1) CA3108835A1 (https=)
WO (1) WO2020030745A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210285949A1 (en) * 2020-03-16 2021-09-16 Sphingotec Gmbh Pro-adrenomedullin or fragment thereof in patients infected with corona virus and treatments with binder against adrenomedullin
EP4133274A1 (en) * 2020-04-06 2023-02-15 B.R.A.H.M.S GmbH Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (sars)
CN116525105B (zh) * 2023-06-29 2023-10-03 中国人民解放军总医院 一种心源性休克预后预测预警系统、设备及可存储介质

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
DE10316583A1 (de) * 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
ES2300681T3 (es) * 2004-07-22 2008-06-16 Brahms Aktiengesellschaft Procedimiento para el diagnostico y tratamiento de pacientes criticos con endotelina, agonistas de endotelina y antagonistas de adrenomedulina.
JP5711131B2 (ja) * 2008-10-07 2015-04-30 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 最初の有害事象の予測のためのバイオマーカー
EP2438447B1 (en) * 2009-06-05 2015-02-18 B.R.A.H.M.S GmbH Detection of bacterial infections in subjects suffering from dyspnea.
WO2012059477A1 (en) * 2010-11-01 2012-05-10 B.R.A.H.M.S Gmbh Prognosis and risk assessment of patients with non-specific complaints
DK2780717T3 (en) * 2011-11-16 2017-02-13 Sphingotec Gmbh ADRENOMEDULLINASSAYS AND METHODS FOR DETERMINING MODERN ADRENOMEDULLIN
US20180348235A1 (en) * 2015-11-27 2018-12-06 B.R.A.H.M.S Gmbh MR-proADM as marker for the extracellular volume status of a subject
EP4231018A3 (en) * 2016-07-08 2023-11-15 SphingoTec GmbH Adrenomedullin for assessing congestion in a subject with acute heart failure
RU2764766C2 (ru) * 2016-08-09 2022-01-21 Б.Р.А.Х.М.С. Гмбх Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции
CA3033094A1 (en) * 2016-08-09 2018-02-15 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating an adverse event

Similar Documents

Publication Publication Date Title
Jha et al. Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation
JP6106277B2 (ja) 尿中エキソソームｍＲＮＡおよびそれを用いて糖尿病性腎症を検出する方法
JP2021534385A5 (https=)
JP7390002B2 (ja) 頭頸部がんの検出を補助する方法
Koziel et al. Comparative analysis of selected scales to assess prognosis in acute pancreatitis
Xie et al. Fecal calprotectin as an alternative to ulcerative colitis endoscopic index of severity to predict the response to corticosteroids of acute severe ulcerative colitis: A prospective observational study
Tran et al. Prevalence and prediction of multiple organ system failure and mortality in acute pancreatitis
JP2015508887A5 (https=)
US12560620B2 (en) Pro-ADM for prognosis of trauma-related complications in polytrauma patients
JP2021525879A5 (https=)
Wu et al. Evaluation of high mobility group box 1 protein as a presurgical diagnostic marker reflecting the severity of acute appendicitis
WO2019117269A1 (ja) 膵がんの検出を補助する方法
WO2019078614A1 (ko) 혈액 내 chi3l1 발현 수준을 이용한 정상압 수두증 진단용 조성물과 진단 마커 검출 방법
JPWO2020030745A5 (https=)
BR112021002281A2 (pt) pro-adm para prognosticar o risco de uma condição médica requerendo hospitalização em pacientes com sintomas de doença infecciosa
RU2674252C2 (ru) Способ прогнозирования тяжести течения и исхода заболевания у пациентов с хирургическим сепсисом
JP2020533604A5 (https=)
JPWO2020169819A5 (https=)
CN111413508A (zh) 尿timp-2和igfbp-7在制备用于诊断脓毒症急性肾损伤的生物标记物中的用途
Margoni et al. Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: A puzzle of autoimmunity
RU2021104644A (ru) Проадм для прогнозирования риска состояния, требующего госпитализации, у пациентов с симптомами инфекционного заболевания
BR112020004150A2 (pt) pct e pro-adm como marcadores para monitorar tratamento de antibiótico
Alam et al. Urinary cell-cycle arrest biomarkers as early predictors of acute kidney injury after ventricular assist device implantation or cardiac transplantation
US20170356046A1 (en) Method for predicting response to continuous positive air pressure treatment
Matos et al. Gitelman syndrome: a rare case of hypokalaemia and a novel mutation